1. Home
  2. FSI vs ANVS Comparison

FSI vs ANVS Comparison

Compare FSI & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexible Solutions International Inc. (CDA)

FSI

Flexible Solutions International Inc. (CDA)

HOLD

Current Price

$6.52

Market Cap

71.3M

ML Signal

HOLD

Logo Annovis Bio Inc.

ANVS

Annovis Bio Inc.

HOLD

Current Price

$1.88

Market Cap

60.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSI
ANVS
Founded
1991
2008
Country
Canada
United States
Employees
N/A
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
60.1M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
FSI
ANVS
Price
$6.52
$1.88
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.50
AVG Volume (30 Days)
20.2K
1.3M
Earning Date
04-15-2026
05-12-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
39.39
EPS
0.06
N/A
Revenue
$15,494,325.00
N/A
Revenue This Year
$63.39
N/A
Revenue Next Year
$43.77
N/A
P/E Ratio
$109.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.55
$1.36
52 Week High
$11.48
$5.50

Technical Indicators

Market Signals
Indicator
FSI
ANVS
Relative Strength Index (RSI) 60.06 44.13
Support Level $6.35 $1.56
Resistance Level $7.40 $2.67
Average True Range (ATR) 0.34 0.14
MACD 0.09 0.03
Stochastic Oscillator 56.52 72.00

Price Performance

Historical Comparison
FSI
ANVS

About FSI Flexible Solutions International Inc. (CDA)

Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.

About ANVS Annovis Bio Inc.

Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.

Share on Social Networks: